Merck and Roche have so far not disclosed whether they intend to begin large Phase III trials for their CETP inhibitors.

• 默克公司和罗氏有到目前为止，还没有透露他们是否打算开始大三期试验，为他们的胆固醇酯转运蛋白抑制剂。